Novel oximes having 5-benzyl-2,4-thiazolidinedione as antihyperglycemic agents: synthesis and structure-activity relationship. (Q54059193)

24 May 2018

title

Novel oximes having 5-benzyl-2,4-thiazolidinedione as antihyperglycemic agents: synthesis and structure-activity relationship. (English)

1 reference

24 May 2018

author name string

Yanagisawa H

1

1 reference

24 May 2018

Takamura M

2

1 reference

24 May 2018

Yamada E

3

1 reference

24 May 2018

Fujita S

4

1 reference

24 May 2018

Fujiwara T

5

1 reference

24 May 2018

Yachi M

6

1 reference

24 May 2018

Isobe A

7

1 reference

24 May 2018

Hagisawa Y

8

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 February 2000

1 reference

24 May 2018

Bioorganic & Medicinal Chemistry Letters

published in

1 reference

24 May 2018

volume

10

1 reference

24 May 2018

issue

4

1 reference

24 May 2018

page(s)

373-375

1 reference

24 May 2018

Diabetes complications: why is glucose potentially toxic?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900003-2

7 January 2021

Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900003-2

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900003-2

7 January 2021

Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900003-2

7 January 2021

Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900003-2

7 January 2021

Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900003-2

7 January 2021

[[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900003-2

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900003-2

7 January 2021

Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900003-2

7 January 2021

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900003-2

7 January 2021

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900003-2

7 January 2021

10.1016/S0960-894X(00)00003-2

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018